Skip to main content

Table 2 Discrimination of PREDICT Prostate (PREDICT) within treatment sub-groups and comparison to other existing tools

From: Comparative performance and external validation of the multivariable PREDICT Prostate tool for non-metastatic prostate cancer: a study in 69,206 men from Prostate Cancer data Base Sweden (PCBaSe)

   

PCSM

 

Overall

 

N

Tool

c-index

SD

p

c-index

SD

p

Conservative management

20,384

PREDICT

0.810

0.010

 

0.740

0.0057

 
 

20,384

EAU

0.746

0.0115

< 0.001

0.636

0.0061

< 0.001

 

20,384

NCCN

0.760

0.0118

< 0.001

0.643

0.0063

< 0.001

 

20,384

CAPRA

0.765

0.0125

< 0.001

0.643

0.0064

< 0.001

Radical treatment

32,842

PREDICT

0.784

0.0122

 

0.670

0.0077

 
 

32,842

EAU

0.742

0.0113

< 0.001

0.606

0.0077

< 0.001

 

32,842

NCCN

0.769

0.0106

0.063

0.617

0.0081

< 0.001

 

32,842

CAPRA

0.780

0.0116

0.475

0.625

0.0082

< 0.001

Overall

69,206

PREDICT

0.852

0.0038

 

0.792

0.0028

 
  1. EAU European Association of Urology criteria, NCCN National Cancer Care Network criteria, CAPRA UCSF Cancer of the prostate risk assessment criteria, SD standard deviation